171 related articles for article (PubMed ID: 36961604)
1. Fecal Immunoglobulin Levels as a Modifier of the Gut Microbiome in Patients with Common Variable Immunodeficiency.
Nöltner C; Bulashevska A; Hübscher K; Haberstroh H; Grimbacher B; Proietti M
J Clin Immunol; 2023 Aug; 43(6):1208-1220. PubMed ID: 36961604
[TBL] [Abstract][Full Text] [Related]
2. Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates.
Bosák J; Lexa M; Fiedorová K; Gadara DC; Micenková L; Spacil Z; Litzman J; Freiberger T; Šmajs D
Front Immunol; 2021; 12():671239. PubMed ID: 34054845
[TBL] [Abstract][Full Text] [Related]
3. Oropharyngeal microbial ecosystem perturbations influence the risk for acute respiratory infections in common variable immunodeficiency.
Pulvirenti F; Giufrè M; Pentimalli TM; Camilli R; Milito C; Villa A; Sculco E; Cerquetti M; Pantosti A; Quinti I
Front Immunol; 2024; 15():1371118. PubMed ID: 38873612
[TBL] [Abstract][Full Text] [Related]
4. Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype.
Fiedorová K; Radvanský M; Bosák J; Grombiříková H; Němcová E; Králíčková P; Černochová M; Kotásková I; Lexa M; Litzman J; Šmajs D; Freiberger T
Front Immunol; 2019; 10():1914. PubMed ID: 31456808
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota in Mexican patients with common variable immunodeficiency.
Franco-Esquivias AP; Peña CG; Torres-Lozano C; Vaca-Paniagua F; Díaz-Velásquez C; Ortega-Cisneros M; Quintero-Ramos A
Gac Med Mex; 2019; 155(5):447-452. PubMed ID: 32091022
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions.
Varricchi G; Poto R; Ianiro G; Punziano A; Marone G; Gasbarrini A; Spadaro G
Front Immunol; 2021; 12():712915. PubMed ID: 34408753
[TBL] [Abstract][Full Text] [Related]
7. Microbiota bacteriana intestinal en pacientes mexicanos con inmunodeficiencia común variable.
Franco-Esquivias AP; García-De la Peña C; Torres-Lozano C; Vaca-Paniagua F; Díaz-Velásquez C; Ortega-Cisneros M; Quintero-Ramos A
Gac Med Mex; 2019; 155(5):481-486. PubMed ID: 31695233
[TBL] [Abstract][Full Text] [Related]
8. Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation.
Jørgensen SF; Trøseid M; Kummen M; Anmarkrud JA; Michelsen AE; Osnes LT; Holm K; Høivik ML; Rashidi A; Dahl CP; Vesterhus M; Halvorsen B; Mollnes TE; Berge RK; Moum B; Lundin KE; Fevang B; Ueland T; Karlsen TH; Aukrust P; Hov JR
Mucosal Immunol; 2016 Nov; 9(6):1455-1465. PubMed ID: 26982597
[TBL] [Abstract][Full Text] [Related]
9. Synergistic convergence of microbiota-specific systemic IgG and secretory IgA.
Fadlallah J; Sterlin D; Fieschi C; Parizot C; Dorgham K; El Kafsi H; Autaa G; Ghillani-Dalbin P; Juste C; Lepage P; Malphettes M; Galicier L; Boutboul D; Clément K; André S; Marquet F; Tresallet C; Mathian A; Miyara M; Oksenhendler E; Amoura Z; Yssel H; Larsen M; Gorochov G
J Allergy Clin Immunol; 2019 Apr; 143(4):1575-1585.e4. PubMed ID: 30554723
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
Front Immunol; 2020; 11():574500. PubMed ID: 33042155
[TBL] [Abstract][Full Text] [Related]
11. Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.
Cabanero-Navalon MD; Garcia-Bustos V; Mira A; Moral Moral P; Salavert-Lleti M; Forner Giner MJ; Núñez Beltrán M; Todolí Parra J; Bracke C; Carda-Diéguez M
Clin Immunol; 2023 Nov; 256():109796. PubMed ID: 37774905
[TBL] [Abstract][Full Text] [Related]
12. Altered Plasma Fatty Acids Associate with Gut Microbial Composition in Common Variable Immunodeficiency.
Skarpengland T; Macpherson ME; Hov JR; Kong XY; Bohov P; Halvorsen B; Fevang B; Berge RK; Aukrust P; Jørgensen SF
J Clin Immunol; 2022 Jan; 42(1):146-157. PubMed ID: 34669143
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study.
Hu X; Du J; Xie Y; Huang Q; Xiao Y; Chen J; Yan S; Gong Z; Ouyang S
BMC Nephrol; 2020 Mar; 21(1):97. PubMed ID: 32169051
[TBL] [Abstract][Full Text] [Related]
14. Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota.
Gill T; Stauffer P; Asquith M; Laderas T; Martin TM; Davin S; Schleisman M; Ramirez C; Ogle K; Lindquist I; Nguyen J; Planck SR; Shaut C; Diamond S; Rosenbaum JT; Karstens L
Front Immunol; 2022; 13():965634. PubMed ID: 36248884
[TBL] [Abstract][Full Text] [Related]
15. Common Variable Immunodeficiency Patient Fecal Microbiota Transplant Recapitulates Gut Dysbiosis.
Hajjar J; Voigt A; Conner M; Swennes A; Fowler S; Calarge C; Mendonca D; Armstrong D; Chang CY; Walter J; Butte M; Savidge T; Oh J; Kheradmand F; Petrosino J
Res Sq; 2023 Mar; ():. PubMed ID: 36993518
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for microbiome-based approach in common variable immunodeficiency?
Poto R; Laniro G; de Paulis A; Spadaro G; Marone G; Gasbarrini A; Varricchi G
Clin Exp Med; 2023 Oct; 23(6):1981-1998. PubMed ID: 36737487
[TBL] [Abstract][Full Text] [Related]
17. [Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors].
Bao WH; Tang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):124-132. PubMed ID: 36718700
[TBL] [Abstract][Full Text] [Related]
18. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
[TBL] [Abstract][Full Text] [Related]
19. Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
Jørgensen SF; Macpherson ME; Bjørnetrø T; Holm K; Kummen M; Rashidi A; Michelsen AE; Lekva T; Halvorsen B; Trøseid M; Mollnes TE; Berge RK; Yndestad A; Ueland T; Karlsen TH; Aukrust P; Hov JR; Fevang B
Sci Rep; 2019 Jan; 9(1):167. PubMed ID: 30655568
[TBL] [Abstract][Full Text] [Related]
20. Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy.
Mohammed AD; Khan MAW; Chatzistamou I; Chamseddine D; Williams-Kang K; Perry M; Enos R; Murphy A; Gomez G; Aladhami A; Oskeritzian CA; Jolly A; Chang Y; He S; Pan Z; Kubinak JL
Front Immunol; 2019; 10():2484. PubMed ID: 31708923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]